BS
Bhim Sain Dhiman
About Bhim Sain Dhiman
Bhim Sain Dhiman has 2 years in corporate governance. Holds Director and Designated Partner roles. Currently with 5 companies, including Cdas Superspeciality Hospital Private Limited and Koushal Business Solutions Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Cdas Superspeciality Hospital Private Limited
U74999HR2017PTC067425
|
Director | 26 Oct 2024 | 2017 | Active |
Koushal Business Solutions Private Limited
U93030DL2008PTC186255
|
Director | 12 Jun 2024 | 2008 | Active |
Major Ashok Healthcare Services Private Limited
U86100HR2022PTC104637
|
Director | 12 Jun 2024 | 2022 | Active |
A Aviation Technical Services Private Limited
U74120DL2007PTC162292
|
Director | 12 Jun 2024 | 2007 | Active |
Shakti Ashok Buildcon Llp
AAL-7543
|
Designated Partner | 23 Oct 2023 | 2018 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhim Sain Dhiman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhim Sain Dhiman
Bhim Sain Dhiman has 2 years in corporate governance. Holds Director and Designated Partner roles. Currently with 5 companies, including Cdas Superspeciality Hospital Private Limited and Koushal Business Solutions Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Bhim Sain Dhiman is associated with 5 companies as Director and Designated Partner.
Bhim Sain Dhiman has expertise in General Business, Healthcare and other sectors.
Bhim Sain Dhiman has 2 years in corporate governance.